1.-136. (canceled)
137. A population of polymeric nanoparticles, comprising:
a plurality of polymeric nanoparticles having an amphiphilic co-polymer as at least one constituent, wherein said amphiphilic co-polymer includes polylactic acid (PLA) as one of its polymeric components,
wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 100 nm and a polydispersity index in a range of about 0.05 and about 0.1
138. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 95 nm.
139. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 90 nm.
140. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 85 nm.
141. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 80 nm.
142. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 75 nm.
143. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 70 nm.
144. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 65 nm.
145. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 60 nm.
146. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 55 nm.
147. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 50 nm.
148. The population of the polymeric nanoparticles of claim 137, wherein said polymeric nanoparticles comprise any of a therapeutic agent or an imaging agent.
149. The population of the polymeric nanoparticles of claim 148, wherein said therapeutic agent is any of a taxane, an epothilone, a boronic acid proteasome inhibitor, and an anti-biotic.
150. The population of the polymeric nanoparticles of claim 148, wherein said therapeutic agent is an anti-neoplastic agent.
151. The population of the polymeric nanoparticles of claim 150, wherein said anti-neoplastic agent is a taxane.
152. The population of the polymeric nanoparticles of claim 151, wherein said taxane is any of paclitaxel, docetaxel, larotaxel and cabazitaxel.
153. The population of the polymeric nanoparticles of claim 137, wherein said population includes at least about 10 grams of said nanoparticles.
154. The population of the polymeric nanoparticles of claim 137, wherein said population includes at least about 50 grams of said nanoparticles.
155. The population of the polymeric nanoparticles of claim 137, wherein said population includes at least about 100 grams of said nanoparticles.
156. The population of the polymeric nanoparticles of claim 137, wherein said population includes at least about 500 grams of said nanoparticles.
157. The population of the polymeric nanoparticles of claim 137, wherein said population comprises a lyoprotectant.
158. A population of polymeric nanoparticles, comprising:
a plurality of polymeric nanoparticles having an amphiphilic co-polymer as at least one constituent, wherein said amphiphilic co-polymer includes polyglycolic acid (PGA) as one of its polymeric components,
wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 100 nm and a polydispersity index in a range of about 0.05 and about 0.1
159. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 95 nm.
160. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 90 nm.
161. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 85 nm.
162. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 80 nm.
163. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 75 nm.
164. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 70 nm.
165. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 65 nm.
166. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 60 nm.
167. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 55 nm.
168. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles exhibit an average particle size equal to or less than about 50 nm.
169. The population of the polymeric nanoparticles of claim 156, wherein said polymeric nanoparticles comprise any of a therapeutic agent or an imaging agent.
170. The population of the polymeric nanoparticles of claim 156, wherein said therapeutic agent is any of a taxane, an epothilone, a boronic acid proteasome inhibitor, and an anti-biotic.
171. The population of the polymeric nanoparticles of claim 168, wherein said therapeutic agent is an anti-neoplastic agent.
172. The population of the polymeric nanoparticles of claim 169, wherein said anti-neoplastic agent is a taxane.
173. The population of the polymeric nanoparticles of claim 170, wherein said taxane is any of paclitaxel, docetaxel, larotaxel and cabazitaxel.
174. The population of the polymeric nanoparticles of claim 156, wherein said population includes at least about 10 grams of said nanoparticles.
175. The population of the polymeric nanoparticles of claim 156, wherein said population includes at least about 50 grams of said nanoparticles.
176. The population of the polymeric nanoparticles of claim 156, wherein said population includes at least about 100 grams of said nanoparticles.
177. The population of the polymeric nanoparticles of claim 156, wherein said population includes at least about 500 grams of said nanoparticles.
178. The population of the polymeric nanoparticles of claim 156, wherein said population comprises a lyoprotectant.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1-18. (canceled)
19. A drainage device for removing dirt particles and wastewater from a cleaning head for cleaning a dryer screen of a paper production plant comprising:
an air-water separation container including an air outlet, a wastewater outlet and an inlet opening for receiving the dirt particles and the wastewater from the cleaning head, the air-water separation container being connected to the cleaning head so as to be movable transversely relative to the dryer screen together with the cleaning head.
20. The drainage device as recited in claim 19, further comprising a tubular body connecting the cleaning head and the air-water separation container.
21. The drainage device as recited in claim 20, wherein the tubular body includes at least one propellant inlet configured to accommodate a propellant.
22. The drainage device as recited in claim 20, wherein the tubular body includes at least one propellant inlet configured to accelerate the dirt particles and wastewater from the cleaning head so as to transport the dirt particles and wastewater through the tubular body.
23. The drainage device as recited in claim 22, wherein the at least one propellant inlet is disposed substantially coaxially with a central axis of the tubular body and is configured to distribute compressed air.
24. The drainage device as recited in claim 22, wherein the at least one propellant inlet is disposed in a direction that is not parallel to a central axis of the tubular body.
25. The drainage device as recited in claim 20; wherein at least one of the tubular body and the cleaning head have a substantially uniform cross section.
26. The drainage device as recited in claim 20, wherein the cleaning head is pivotably connected to the tubular body.
27. The drainage device as recited in claim 19, wherein the air-water separation container includes a removable cover.
28. The drainage device as recited in claim 19, wherein the air-water separation container is cylindrical.
29. The drainage device as recited in claim 19, wherein the air-water separation container includes a cross-section that tapers in a funnel-shaped manner towards the waste water outlet.
30. The drainage device as recited in claim 19, wherein at least one of the drainage device and the cleaning head include thermally insulated wall surfaces.
31. The drainage device as recited in claim 19, wherein the inlet opening is an inflow into the air-water separation container having a directional component that is not perpendicular to a lateral inner face of the air-water separation container such that incoming dirt particles and wastewater form a vortex-like flow in the air-water separation container.
32. The drainage device as recited in claim 19, further comprising a wastewater hose connected to the wastewater outlet and leading to a stationary drainage system.
33. The drainage device as recited in claim 32, further comprising an angled tube piece connecting the wastewater hose to the wastewater outlet and a device configured to movably carry cables connecting the wastewater hose to the stationary drainage system.
34. A method for carrying off dirt particles and wastewater from a cleaning head for cleaning a dryer screen in a paper production plant, the method comprising:
moving the cleaning head transversely with respect to the dryer screen so as to entrain an air-water separation container;
collecting the dirt particles and the wastewater in a suspension separating air in the air-water separation container;
discharging the air from an air outlet in the air-water separation container; and
discharging the suspension from a wastewater outlet in the air-water separation container.
35. The method as recited in claim 34, further comprising injecting a propellant into a tubular body connecting the cleaning head and the air-water separation container so as to accelerate the dirt particles and the wastewater.
36. The method as recited in claim 34, further comprising injecting a propellant into a tubular body connecting the cleaning head and the air-water separation container so as to produce one of a spiral and a helical flow.
37. The method as recited in claim 34, further comprising producing a vortex-like flow in the air-water separation container.
38. The method as recited in claim 34, wherein the method is performed during a cleaning process of the dryer screen.
39. The method as recited in claim 38, wherein the cleaning process is performed at the same time as a paper production process.
40. The method as recited in claim 35, further comprising measuring a fill level of at least one of the dirt particles and the wastewater, the propellant and the suspension using at least one fill level sensor.